Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis.

导出 OA

翻译打印收藏纠错

作者： Elgin,Hoffmann ^[1] ; Chiara,De-Colle ^[2] ; Vlatko,Potkrajcic ^[2] ; David,Baumann ^[2] ; Werner,Spengler ^[3] ; Cihan,Gani ^[2] ; David,Utz ^[3]

作者单位： Department of Radiation Oncology, Eberhard-Karls University Tübingen, 72076, Tübingen, Germany. elgin.hoffmann@med.uni-tuebingen.de. ^[1] Department of Radiation Oncology, Eberhard-Karls University Tübingen, 72076, Tübingen, Germany. ^[2] Department of Medical Oncology and Pneumology, Eberhard-Karls University Tübingen, 72076, Tübingen, Germany. ^[3]

关键词 Chemoimmunotherapy Consolidative thoracic radiotherapy PD-L1 inhibitor Radiotherapy and immunotherapy Small cell lung cancer, extensive stage

主题词人类(Humans);小细胞肺癌(Small Cell Lung Carcinoma);肺肿瘤(Lung Neoplasms);回顾性研究(Retrospective Studies);前瞻性研究(Prospective Studies);免疫疗法(Immunotherapy)

DOI 10.1007/s00066-023-02075-9

PMID 37039832

发布时间 2023-07-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交